Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
GlobalData on MSN15h
Struggling bluebird bio to go private for less than $30mBluebird bio will be acquired by investment firms Carlyle and SK Capital Partners, marking the end to its turbulent time as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback